# DXP Enterprises Inc: financial statements, quarterly DXPE · Nasdaq · CIK 1020710 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/dxpe.md) · [Financials](/companies/dxpe/financials.md) · [Filings](/companies/dxpe/filings.md) · [Insiders](/companies/dxpe/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/dxpe/financials.md?period=annual). ## Income statement | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [419](/filings/0001020710-24-000097.md) | [407 d](/filings/0001628280-26-012382.md) | [413](/filings/0001020710-25-000092.md) | [446](/filings/0001020710-25-000137.md) | [473](/filings/0001628280-25-050322.md) | [471 d](/filings/0001628280-26-012382.md) | [477](/filings/0001628280-26-032353.md) | [499](/filings/0001628280-26-054179.md) | [514](/filings/0001628280-25-050322.md) | [527 d](/filings/0001628280-26-012382.md) | [522](/filings/0001628280-26-032353.md) | [576](/filings/0001628280-26-054179.md) | | Cost of revenue | $m | [294](/filings/0001020710-24-000097.md) | [284 d](/filings/0001628280-26-012382.md) | [289](/filings/0001020710-25-000092.md) | [308](/filings/0001020710-25-000137.md) | [327](/filings/0001628280-25-050322.md) | [322 d](/filings/0001628280-26-012382.md) | [326](/filings/0001628280-26-032353.md) | [341](/filings/0001628280-26-054179.md) | [352](/filings/0001628280-25-050322.md) | [361 d](/filings/0001628280-26-012382.md) | [353](/filings/0001628280-26-032353.md) | [393](/filings/0001628280-26-054179.md) | | Gross profit | $m | [126](/filings/0001020710-24-000097.md) | [123 d](/filings/0001628280-26-012382.md) | [124](/filings/0001020710-25-000092.md) | [138](/filings/0001020710-25-000137.md) | [146](/filings/0001628280-25-050322.md) | [148 d](/filings/0001628280-26-012382.md) | [150](/filings/0001628280-26-032353.md) | [158](/filings/0001628280-26-054179.md) | [161](/filings/0001628280-25-050322.md) | [167 d](/filings/0001628280-26-012382.md) | [169](/filings/0001628280-26-032353.md) | [183](/filings/0001628280-26-054179.md) | | Selling, general and administrative | $m | [89.7](/filings/0001020710-24-000097.md) | [92.8 d](/filings/0001628280-26-012382.md) | [94.8](/filings/0001020710-25-000092.md) | [100](/filings/0001020710-25-000137.md) | [107](/filings/0001628280-25-050322.md) | [109 d](/filings/0001628280-26-012382.md) | [110](/filings/0001628280-26-032353.md) | [112](/filings/0001628280-26-054179.md) | [118](/filings/0001628280-25-050322.md) | [120 d](/filings/0001628280-26-012382.md) | [126](/filings/0001628280-26-032353.md) | [128](/filings/0001628280-26-054179.md) | | Operating income | $m | [35.9](/filings/0001020710-24-000097.md) | [30.0 d](/filings/0001628280-26-012382.md) | [29.1](/filings/0001020710-25-000092.md) | [37.4](/filings/0001020710-25-000137.md) | [39.6](/filings/0001628280-25-050322.md) | [39.3 d](/filings/0001628280-26-012382.md) | [40.5](/filings/0001628280-26-032353.md) | [46.0](/filings/0001628280-26-054179.md) | [43.7](/filings/0001628280-25-050322.md) | [46.7 d](/filings/0001628280-26-012382.md) | [42.5](/filings/0001628280-26-032353.md) | [55.5](/filings/0001628280-26-054179.md) | | Interest expense | $m | [12.7](/filings/0001020710-23-000101.md) | [17.1 d](/filings/0001020710-24-000026.md) | [15.5](/filings/0001020710-24-000055.md) | [15.4](/filings/0001020710-25-000137.md) | [15.7](/filings/0001628280-25-050322.md) | [17.3 d](/filings/0001628280-26-012382.md) | [14.7](/filings/0001628280-26-032353.md) | [14.7](/filings/0001628280-26-054179.md) | [14.9](/filings/0001628280-25-050322.md) | [16.2 d](/filings/0001628280-26-012382.md) | [16.4](/filings/0001628280-26-032353.md) | [16.8](/filings/0001628280-26-054179.md) | | Income tax | $m | [5.8](/filings/0001020710-24-000097.md) | [(1.2) d](/filings/0001628280-26-012382.md) | [4.2](/filings/0001020710-25-000092.md) | [6.3](/filings/0001020710-25-000137.md) | [2.6](/filings/0001628280-25-050322.md) | [1.3 d](/filings/0001628280-26-012382.md) | [6.6](/filings/0001628280-26-032353.md) | [8.0](/filings/0001628280-26-054179.md) | [7.8](/filings/0001628280-25-050322.md) | [8.2 d](/filings/0001628280-26-012382.md) | [6.6](/filings/0001628280-26-032353.md) | [11.0](/filings/0001628280-26-054179.md) | | Net income | $m | [16.2](/filings/0001020710-24-000097.md) | [16.0 d](/filings/0001628280-26-012382.md) | [11.3](/filings/0001628280-25-050322.md) | [16.7](/filings/0001628280-25-050322.md) | [21.1](/filings/0001628280-25-050322.md) | [21.4 d](/filings/0001628280-26-012382.md) | [20.6](/filings/0001628280-26-054179.md) | [23.6](/filings/0001628280-26-054179.md) | [21.6](/filings/0001628280-25-050322.md) | [22.8 d](/filings/0001628280-26-012382.md) | [20.0](/filings/0001628280-26-054179.md) | [28.7](/filings/0001628280-26-054179.md) | | Diluted EPS | $ per share | [0.93](/filings/0001020710-24-000097.md) | not reported | [0.67](/filings/0001020710-25-000092.md) | [1.00](/filings/0001020710-25-000137.md) | [1.27](/filings/0001628280-25-050322.md) | not reported | [1.25](/filings/0001628280-26-032353.md) | [1.43](/filings/0001628280-26-054179.md) | [1.31](/filings/0001628280-25-050322.md) | not reported | [1.22](/filings/0001628280-26-032353.md) | [1.76](/filings/0001628280-26-054179.md) | | Basic EPS | $ per share | [0.98](/filings/0001020710-24-000097.md) | not reported | [0.70](/filings/0001020710-25-000092.md) | [1.05](/filings/0001020710-25-000137.md) | [1.34](/filings/0001628280-25-050322.md) | not reported | [1.31](/filings/0001628280-26-032353.md) | [1.50](/filings/0001628280-26-054179.md) | [1.38](/filings/0001628280-25-050322.md) | not reported | [1.28](/filings/0001628280-26-032353.md) | [1.85](/filings/0001628280-26-054179.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Cost of revenue: us-gaap:CostOfGoodsAndServicesSold - Gross profit: us-gaap:GrossProfit - Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [27.2](/filings/0001020710-23-000101.md) | [173](/filings/0001020710-25-000036.md) | [140](/filings/0001020710-24-000055.md) | [49.9](/filings/0001020710-24-000072.md) | [35.0](/filings/0001020710-24-000097.md) | [148](/filings/0001628280-26-012382.md) | [114](/filings/0001020710-25-000092.md) | [113](/filings/0001020710-25-000137.md) | [124](/filings/0001628280-25-050322.md) | [304](/filings/0001628280-26-054179.md) | [213](/filings/0001628280-26-032353.md) | [227](/filings/0001628280-26-054179.md) | | Current assets | $m | [517](/filings/0001020710-23-000101.md) | [649](/filings/0001020710-25-000036.md) | [617](/filings/0001020710-24-000055.md) | [544](/filings/0001020710-24-000072.md) | [555](/filings/0001020710-24-000097.md) | [662](/filings/0001628280-26-012382.md) | [662](/filings/0001020710-25-000092.md) | [684](/filings/0001020710-25-000137.md) | [727](/filings/0001628280-25-050322.md) | [910](/filings/0001628280-26-054179.md) | [851](/filings/0001628280-26-032353.md) | [889](/filings/0001628280-26-054179.md) | | Total assets | $m | [1,045](/filings/0001020710-23-000101.md) | [1,177](/filings/0001020710-25-000036.md) | [1,184](/filings/0001020710-24-000055.md) | [1,189](/filings/0001020710-24-000072.md) | [1,231](/filings/0001020710-24-000097.md) | [1,349](/filings/0001628280-26-012382.md) | [1,383](/filings/0001020710-25-000092.md) | [1,412](/filings/0001020710-25-000137.md) | [1,444](/filings/0001628280-25-050322.md) | [1,685](/filings/0001628280-26-054179.md) | [1,725](/filings/0001628280-26-032353.md) | [1,770](/filings/0001628280-26-054179.md) | | Current liabilities | $m | [222](/filings/0001020710-23-000101.md) | [224](/filings/0001020710-25-000036.md) | [229](/filings/0001020710-24-000055.md) | [228](/filings/0001020710-24-000072.md) | [249](/filings/0001020710-24-000097.md) | [244](/filings/0001628280-26-012382.md) | [245](/filings/0001020710-25-000092.md) | [245](/filings/0001020710-25-000137.md) | [262](/filings/0001628280-25-050322.md) | [272](/filings/0001628280-26-054179.md) | [286](/filings/0001628280-26-032353.md) | [297](/filings/0001628280-26-054179.md) | | Total liabilities | $m | [682](/filings/0001020710-23-000101.md) | [797](/filings/0001020710-25-000036.md) | [809](/filings/0001020710-24-000055.md) | [804](/filings/0001020710-24-000072.md) | [829](/filings/0001020710-24-000097.md) | [927](/filings/0001628280-26-012382.md) | [938](/filings/0001020710-25-000092.md) | [944](/filings/0001020710-25-000137.md) | [956](/filings/0001628280-25-050322.md) | [1,187](/filings/0001628280-26-054179.md) | [1,213](/filings/0001628280-26-032353.md) | [1,229](/filings/0001628280-26-054179.md) | | Long-term debt | $m | [408](/filings/0001020710-23-000101.md) | [521](/filings/0001020710-25-000036.md) | [520](/filings/0001020710-24-000055.md) | [520](/filings/0001020710-24-000072.md) | [519](/filings/0001020710-24-000097.md) | [622](/filings/0001628280-26-012382.md) | [621](/filings/0001020710-25-000092.md) | [620](/filings/0001020710-25-000137.md) | [619](/filings/0001628280-25-050322.md) | [818](/filings/0001628280-26-054179.md) | [817](/filings/0001628280-26-032353.md) | [816](/filings/0001628280-26-054179.md) | | Current portion of debt | $m | [4.4](/filings/0001020710-23-000101.md) | [5.5](/filings/0001020710-25-000036.md) | [5.5](/filings/0001020710-24-000055.md) | [5.5](/filings/0001020710-24-000072.md) | [5.5](/filings/0001020710-24-000097.md) | [6.6](/filings/0001628280-26-012382.md) | [6.6](/filings/0001020710-25-000092.md) | [6.6](/filings/0001020710-25-000137.md) | [6.6](/filings/0001628280-25-050322.md) | [8.6](/filings/0001628280-26-054179.md) | [8.6](/filings/0001628280-26-032353.md) | [8.6](/filings/0001628280-26-054179.md) | | Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Shareholders' equity | $m | [364](/filings/0001020710-23-000101.md) | [381](/filings/0001628280-26-012382.md) | [375](/filings/0001628280-25-050322.md) | [385](/filings/0001628280-25-050322.md) | [402](/filings/0001628280-25-050322.md) | [423](/filings/0001628280-26-054179.md) | [445](/filings/0001628280-26-054179.md) | [468](/filings/0001628280-26-054179.md) | [488](/filings/0001628280-25-050322.md) | [498](/filings/0001628280-26-054179.md) | [512](/filings/0001628280-26-054179.md) | [541](/filings/0001628280-26-054179.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: us-gaap:LongTermDebtNoncurrent - Current portion of debt: us-gaap:DebtCurrent, us-gaap:LongTermDebtCurrent - Short-term borrowings: not reported - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [39.8 d](/filings/0001020710-24-000097.md) | [42.4 d](/filings/0001628280-26-012382.md) | [27.0](/filings/0001020710-25-000092.md) | [14.7 d](/filings/0001020710-25-000137.md) | [28.3 d](/filings/0001628280-25-050322.md) | [32.1 d](/filings/0001628280-26-012382.md) | [3.0](/filings/0001628280-26-032353.md) | [18.6 d](/filings/0001628280-26-054179.md) | [34.9 d](/filings/0001628280-25-050322.md) | [37.8 d](/filings/0001628280-26-012382.md) | [29.6](/filings/0001628280-26-032353.md) | [32.4 d](/filings/0001628280-26-054179.md) | | Capital expenditure | $m | [1.5 d](/filings/0001020710-24-000097.md) | [5.2 d](/filings/0001628280-26-012382.md) | [2.9](/filings/0001020710-25-000092.md) | [8.8 d](/filings/0001020710-25-000137.md) | [4.0 d](/filings/0001628280-25-050322.md) | [9.4 d](/filings/0001628280-26-012382.md) | [19.9](/filings/0001628280-26-032353.md) | [10.3 d](/filings/0001628280-26-054179.md) | [6.7 d](/filings/0001628280-25-050322.md) | [3.3 d](/filings/0001628280-26-012382.md) | [3.3](/filings/0001628280-26-032353.md) | [2.6 d](/filings/0001628280-26-054179.md) | | Dividends paid | $m | not reported | not reported | [0.0](/filings/0001020710-25-000092.md) | [0.0 d](/filings/0001020710-25-000137.md) | [0.0 d](/filings/0001628280-25-050322.md) | [0.0 d](/filings/0001628280-26-012382.md) | [0.0](/filings/0001628280-26-032353.md) | [0.0 d](/filings/0001628280-26-054179.md) | [0.0 d](/filings/0001628280-25-050322.md) | [0.0 d](/filings/0001628280-26-012382.md) | [0.0](/filings/0001628280-26-032353.md) | [0.0 d](/filings/0001628280-26-054179.md) | | Share repurchases | $m | [22.6 d](/filings/0001020710-24-000097.md) | [0.0 d](/filings/0001628280-26-012382.md) | [14.8](/filings/0001020710-25-000092.md) | [9.2 d](/filings/0001020710-25-000137.md) | [4.8 d](/filings/0001628280-25-050322.md) | [0.2 d](/filings/0001628280-26-012382.md) | [0.0](/filings/0001020710-25-000092.md) | [0.0 d](/filings/0001020710-25-000137.md) | [2.0 d](/filings/0001628280-25-050322.md) | [15.1 d](/filings/0001628280-26-012382.md) | not reported | not reported | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Dividends paid: us-gaap:PaymentsOfDividends - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [19.7](/filings/0001020710-23-000101.md) | [18.4](/filings/0001020710-24-000055.md) | [18.1](/filings/0001020710-24-000072.md) | [17.4](/filings/0001020710-24-000097.md) | [17.0](/filings/0001020710-25-000092.md) | [16.7](/filings/0001020710-25-000137.md) | [16.6](/filings/0001628280-25-050322.md) | [16.5](/filings/0001628280-26-032353.md) | [16.5](/filings/0001628280-26-054179.md) | [16.5](/filings/0001628280-25-050322.md) | [16.4](/filings/0001628280-26-032353.md) | [16.3](/filings/0001628280-26-054179.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 15,517,148 at 2026-08-03, from the cover of the [10-Q filed 2026-08-06](/filings/0001628280-26-054179.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:30 ET. No prices; not investment advice.